Effect of AMR101 (Ethyl Icosapentate) on Triglyceride (Tg) Levels in Patients on Statins With High Tg Levels (≥ 200 and < 500 mg/dL)

Clinical trial NCT01047501 · COMPLETED

Trial details

NCT number: NCT01047501
Sponsor: Amarin Pharma Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Hypertriglyceridemia

Start date: 2009-12-01
Primary completion: 2011-02-01
Enrollment: 702

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.